Corrigendum to “The Clinical Impact of Mrna Therapeutics in the Treatment of Cancers, Infections, Genetic Disorders, and Autoimmune Diseases” [Heliyon Volume 10, Issue 5, March 2024, Article E26971](S2405844024030020)(10.1016/J.Heliyon.2024.E26971) Publisher



Deyhimfar R^{1, 2} ; Izady M¹ ; Shoghi M³ ; Kazazi MH⁴ ; Ghazvini ZF⁵ ; Nazari H⁶ ; Fekrirad Z^{7, 8} ; Arefian E^{8, 9}
Source: Heliyon Published:2025

Abstract

In the original published version of this article, the authors incorrectly cited the original reference [117] as it is irrelevant to its respective statement. The original version of reference [117] can be found below. [117] N.J. Vickers, Animal communication: when i'm calling you, will you answer too? Curr. Biol. 27 (14) (2017) R713–R715. The correct version of reference [117] can be found below. [117] Magadum A, Singh N, Kurian AA, Sharkar MTK, Chepurko E, Zangi L. Ablation of a singleN-glycosylation site in human FSTL 1 induces cardiomyocyte proliferation and cardiac regeneration. Molecular Therapy-Nucleic Acids. 2018; 13:133–143. The authors apologize for the errors. Both the HTML and PDF versions of the article have been updated to correct the errors. © 2025 The Author(s)